South African pharma tycoon Stephen Saad's Aspen shares gain $142 million in 2026
Aspen Pharmacare's founder holds shares worth $558.7 million after a 34% rally this year, yet the stake remains $1 billion below its 2015 peak.
Mounjaro
Stephen Saad's Aspen Pharmacare predicts double-digit growth despite tough first half
Aspen Pharmacare reported a steep drop in first-half earnings due to one-off restructuring costs but expects double-digit profit growth by year-end.